References
Briot, K., Tubiana-Hulin, M., Bastit, L., Kloos, I., & Roux, C. (2010). Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: The ATOLL (articular tolerance of letrozole) study. Breast Cancer Research and Treatment, 120, 127-134.
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Bulchholz, T. A., Davidson, N. E.… Griggs, J. J. (2010). American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. Journal of Clinical Oncology, 28, 3748-3796.
Christensen, B. V., Iuhl, I. U., Vilbek, H., Bulow, H. H., Dreijer, N. C., & Rasmussen, H. F. (1992). Acupuncture treatment of severe knee osteoarthrosis. A long-term study. Acta Anaesthesiologica Scandinavica, 36, 519-525. doi:10.1111/j.1399-6576.1992.tb03511.x
Crew, K. D., Capodice, J. L., Greenlee, H., Apollo, A., Jacobson, J. S., Raptis, G., … Hershman, D. L. (2007). Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. Journal of Cancer Survivorship, 1, 283-291.
Crew, K. D., Capodice, J. L., Greenlee, H., Brafman, L., Fuentes, D., Awad, D., … Hershman, D. L. (2010). Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. Journal of Clinical Oncology, 28, 1154-1160.
Crew, K. D., Greenlee, H., Capodice, J., Raptis, G., Brafman, L., Fuentes, D., … Hershman, D. L. (2007). Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. Journal of Clinical Oncology, 25, 3877-3883.
Dent, S. F., Gaspo, R., Kissner, M., & Pritchard, K. I. (2011). Aromatase inhibitor therapy: Toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Research Treatment, 126, 295-310. doi:10.1007/s10549-011-1351-3
Dietrich, W., Haitel, A., Holzer, G., Huber, J. C., Kolbus, A., & Tschugguel, W. (2006). Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. Journal of the Society for Gynecologic Investigation, 13, 512-517.
Din, O. S., Dodwell, D., Wakefield, R. J., & Coleman, R. E. (2010). Aromatase inhibitor-induced arthralgia in early breast cancer: What do we know and how can we find out more? Breast Cancer Research and Treatment, 120, 525-538.
Dizdar, O., Ozcakar, L., Malas, F. U., Harputluoglu, H., Bulut, N., Aksoy, S., … Altundag, K. (2009). Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. Journal of Clinical Oncology, 27, 4955-4960.
Dowsett, M., Cuzick, J., Ingle, J., Coates, A., Forbes, J., Bliss, J., … Peto, R. (2010). Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. Journal of Clinical Oncology, 28, 509-518. doi:10.1200/JCO.2009.23.1274
Ernst, E., Lee, M., & Choi, T. (2011). Acupuncture: Does it alleviate pain and are there serious risks? A review of reviews. Pain, 152, 755-764. doi:10.1016/j.pain.2010.11.004
Ezzo, J., Hadhazy, V., Birch, S., Lao, L., Kaplan, G., Hochberg, M., & Berman, B. (2001). Acupuncture for osteoarthritis of the knee: A systematic review. Arthritis and Rheumatism, 44, 819-825. doi:10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P
Fernihough, J. K., Richmond, R. S., Carlson, C. S., Cherpes, T., Holly, J. M., & Loeser, R. F. (1999). Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis and Rheumatism, 42, 2103-2111.
Freedman, R. A., & Winer, E. P. (2010). Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer. Breast, 19, 69-75. doi:10.1016/j.breast.2009.11.009
Guise, T. A., Brufsky, A., & Coleman, R. E. (2010). Understanding and optimizing bone health in breast cancer. Current Medical Research and Opinion, 26(Suppl. 3), 3-20.
Hall, H. (2011). Acupuncture claims punctured: Not proven effective for pain, not harmless. Pain, 152, 711-712.
Henry, N. L., Azzouz, F., Desta, Z., Li, L., Nguyen, A. T., Lemler, S., … Storniolo, A. M. (2012). Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early stage breast cancer. Journal of Clinical Oncology, 30, 936-942.
Henry, N. L., Giles, J. T., Ang, D., Mohan, M., Dadabhoy, D., Robarge, J., … Clauw, D. J. (2008). Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Research and Treatment, 111, 365-372. doi:10.1007/s10549-007-9774-6
Henry, N. L., & Stearns, V. (2010). One size does not fit all: Quality of life during adjuvant aromatase inhibitor therapy. Breast Cancer Research and Treatment, 125, 751-753.
Ingle, J. N., Schaid, D. J., Goss, P. E., Liu, M., Mushiroda, T., Chapman, J. A., … Weinshilboum, R. M. (2010). Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. Journal of Clinical Oncology, 28, 4674-4682. doi:10.1200/JCO.2010.28.5064
Jones, S. E., Cantrell, J., Vukelja, S., Pippen, J., O'Shaughnessy, J., Blum, J. L., … Asmar, L. (2007). Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy. Journal of Clinical Oncology, 25, 4765-4771. doi:10.1200/JCO.2007.10.8274
Josefsson, M. L., & Leinster, S. J. (2010). Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for estrogen sensitive early breast cancer in post-menopausal women: Meta-analyses of monotherapy, sequenced therapy, and extended therapy. Breast, 19, 76-83. doi:10.1016/j.breast.2009.12.010
Khan, Q. J., Reddy, P. S., Kimler, B. F., Sharma, P., Baxa, S. E., O'Dea, A. P., … Fabian, C. J. (2010). Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Research and Treatment, 119, 111-118. doi:10.1007/s10549-009-0495-x
Mao, J. J., Stricker, C., Bruner, D., Xie, S., Bowman, M. A., Farrar, J. T., … DeMichele, A. (2009). Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer, 115, 3631-3639. doi:10.1002/cncr.24419
Miaskowski, C., Shockney, L., & Chlebowski, R. T. (2008). Adherence to oral endocrine therapy for breast cancer: A nursing perspective. Clinical Journal of Oncology Nursing, 12, 213-221.
Millar, A. (2009). Exercise prescription for people with arthritis. In American College of Sports Medicine (Ed.), ACSM's resources manual for guidelines for exercise testing and prescription (6th ed., pp. 661-665). Philadelphia, PA: Lippincott Williams and Wilkins.
Morales, L., Pans, S., Paridaens, R., Westhovens, R., Timmerman, D., … Neven, P. (2007). Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: Associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Researchand Treatment, 104, 87-91. doi:10.1007/s10549-006-9394-6
Morales, L., Pans, S., Verschueren, K., Van Calster, B., Paridaens, R., Westhovens, R., … Neven, P. (2008). Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. Journal of Clinical Oncology, 26, 3147-3152. doi:10.1200/JCO.2007.15.4005
Offit, K., & Robson, M. E. (2010). New pharmacogenomic paradigm in breast cancer treatment. Journal of Clinical Oncology, 28, 4665-4666. doi:10.1200/JCO.2010.31.2926
Presant, C. A., Bosserman, L., Young, T., Vakil, M., Horns, R., Upadhyaya, G., … Howard, F. (2007). Aromatase inhibitor-associated arthralgia and/or bone pain: Frequency and characterization in nonclinical trial patients. Clinical Breast Cancer, 7, 775-778.
Prieto-Alhambra, D., Javaid, M. K., Servitja, S., Arden, N. K., Martinez-Garcia, M., Diez-Perez, A., … Nogues, X. (2011). Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: A prospective cohort study. Breast Cancer Research and Treatment, 125, 869-878. doi:10.1007/s10549-010-1075-9
Sugamata, N., Koibuchi, Y., Iino, Y., & Morishita, Y. (1999). A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors. International Journal of Oncology, 14, 259-263.
Takeda, W., & Wessel, J. (1994). Acupuncture for the treatment of pain of osteoarthritic knees. Arthritis Care and Research, 7, 118-122. doi:10.1002/art.1790070304
Vanderschueren, D., van Herck, E., Nijs, J., Ederveen, A. G., De Coster, R., & Bouillon, R. (1997). Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology, 138, 2301-2307.
Waltman, N. L., Ott, C. D., Twiss, J. J., Gross, G. J., & Lindsey, A. M. (2009). Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nursing, 32, 143-150. doi:10.1097/01.NCC.0000339262.44560.92
Zhang, Y., McAlindon, T. E., Hannan, M. T., Chaisson, C. E., Klein, R., Wilson, P. W., & Felson, D. T. (1998). Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: The Framingham study. Arthritis and Rheumatism, 41, 1867-1873.